GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NFL Biosciences SA (XPAR:ALNFL) » Definitions » Short-Term Debt

NFL Biosciences (XPAR:ALNFL) Short-Term Debt : €0.06 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is NFL Biosciences Short-Term Debt?

NFL Biosciences's Short-Term Debt for the quarter that ended in Dec. 2023 was €0.06 Mil.

NFL Biosciences's quarterly Short-Term Debt declined from Dec. 2022 (€0.08 Mil) to Jun. 2023 (€0.07 Mil) and declined from Jun. 2023 (€0.07 Mil) to Dec. 2023 (€0.06 Mil).

NFL Biosciences's annual Short-Term Debt declined from Dec. 2021 (€0.09 Mil) to Dec. 2022 (€0.08 Mil) and declined from Dec. 2022 (€0.08 Mil) to Dec. 2023 (€0.06 Mil).


NFL Biosciences Short-Term Debt Historical Data

The historical data trend for NFL Biosciences's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NFL Biosciences Short-Term Debt Chart

NFL Biosciences Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Debt
Get a 7-Day Free Trial - 0.09 0.09 0.08 0.06

NFL Biosciences Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Short-Term Debt Get a 7-Day Free Trial 0.09 0.01 0.08 0.07 0.06

NFL Biosciences Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


NFL Biosciences Short-Term Debt Related Terms

Thank you for viewing the detailed overview of NFL Biosciences's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


NFL Biosciences (XPAR:ALNFL) Business Description

Traded in Other Exchanges
Address
199 rue Helene Boucher, Castelnau-le-Lez, FRA, 34170
NFL Biosciences SA specializes in the research and development of medicines to combat tobacco addiction that use botanical and pharmaceutical agents. NFL-101 is company's core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins.

NFL Biosciences (XPAR:ALNFL) Headlines

No Headlines